A Day Up For Arbutus Biopharma Corporation

Arbutus Biopharma Corporation (ABUS:NASDAQ) soared at $4.61, representing a gain of 44.1%. On Tue, Nov 30, 2021, ABUS:NASDAQ hit a New 2-Week Intraday Low of $3.01. The stock got featured on our News Catalysts scanner on Wed, Dec 01, 2021 at 02:50 PM in the 'PATENT' category. From Tue, Nov 16, 2021, the stock recorded 55.56% Up Days and 50.00% Green Days

The stock spiked on Mon, Sep 27, 2021 at $4.74 with a volume of 2M+, and its share price has been moving sideways in recent weeks.

About Arbutus Biopharma Corporation (ABUS:NASDAQ)

Arbutus Biopharma Corp is a biopharmaceutical business engaged in advancing novel RNA interference therapeutics and discovering, developing and commercializing a cure for patients suffering from chronic hepatitis B infection.